NL-OMON26944尚未招募不适用
SOM230 Graves Orbitopathy pilot trial.
Academic Medical Center Amsterdam0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
Optimal management of Graves orbitopathy: a multidisciplinary approach. Soeters MR, van Zeijl CJJ, Boelen A, Kloos R, Saeed P, Vriesendorp TM, et al. The Netherlands journal of medicine. 69(7):302–8.
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. Bartalena L, Krassas GE, Wiersinga W, Marcocci C, Salvi M, Daumerie C, Bournaud C, Stahl M, Sassi L, Veronesi G, Azzolini C, Boboridis KG, Mourits MP, Soeters MR, Baldeschi L, Nardi M, Currò N, Boschi A, Bernard M, von Arx G; European Group on Graves' Orbitopathy. J Clin Endocrinol Metab. 2012 Dec;97(12):4454-63.
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Moderate – severe GO;
- •2. Corticosteroids contraindicated due to diabetes mellitus, severe osteoporosis, heart failure, psychosis, infectious diseases or other clinical relevant comorbidities;
排除标准
- •1. Inability/refusal to give informed consent;
- •2. Pregnancy;
研究者
相似试验
撤回
不适用
SOM230 Graves Orbitopathy pilot trialGraves Orbitopathy/Eye Disease1004373910003816NL-OMON38562Academisch Medisch Centrum12
招募中
不适用
Pilot study of SOM230 for Treatment of Graves’ OphthalmopathyDiseases of the eye and adnexaKCT0001645Yonsei University Health System, Severance Hospital20
已完成
不适用
Sirolimus in Graves' OrbitopathyGraves OphthalmopathyNCT05345119University of Pisa30
尚未招募
2 期
Sirolimus for Graves' Orbitopathy (GO)Graves OphthalmopathyNCT04598815University of Pisa54
尚未招募
3 期
A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 StudyGraves' OrbitopathyNCT05049603University of Pisa102